Headache Center: Migraine research, migraine diagnostics, migraine therapy, headache research, headache diagnostics and headache therapy
In Germany, about two-thirds of students suffer from headaches. It's high time something changed! The initiators of the action day against migraines and headaches at the Dresden University of Technology (from left to right): Dr. Astrid [...]
Headaches are one of the most common symptoms that general practitioners encounter in their daily practice. In Germany, over 8 million people suffer from migraines within a single year. To help patients in the long term, [...]
BKK expert chat on the topic of migraines, Gütersloh, September 6, 2019. Migraine attacks are excruciating, often incapacitating sufferers for several days. What is the right treatment? What can be done to prevent them? These questions will be discussed in the expert chat next [...]
Frankfurt am Main and Kiel, September 4, 2019. Over 70% of students in Germany suffer from recurring headaches. Migraine attacks and tension-type headaches could often be prevented. This is the conclusion of the accompanying research [...]
Important change: The planned public patient day on September 21, 2019, has to be postponed due to current circumstances. A new date will be announced. ----------------------------------------------- Our joint patient information day of the Kiel Pain Clinic and the Federal Association of Cluster Headache Self-Help Groups (CSG) [...]
Modern therapy for migraines, headaches, and other pain disorders relies not only on medication but also incorporates behavioral medicine treatment methods. Numerous scientific studies confirm the effectiveness of specific relaxation techniques, such as progressive muscle relaxation, [...]
Are you looking for a fulfilling role? Do you have empathy, passion for your dream job, and talent? Then you've come to the right place! We have so much to do and look forward to receiving your application for the position of [...]
Berlin, July 10, 2019. Cabinet approves draft Digital Healthcare Act – Federal Health Minister Jens Spahn: “Digital healthcare is patient-friendly.” Apps on prescription, interesting offers for online consultations, and the possibility of accessing the secure data network throughout treatment [...]
Image: Silvio Rahr (Managing Director of Wir für Gesundheit GmbH) and Prof. Dr. Hartmut Göbel (Chief Physician of the Kiel Pain Clinic). The Kiel Pain Clinic is a new partner of the growing, cross-institutional quality network "Wir für Gesundheit" (We for Health). The network comprises more than 230 [...]
For over ten years, we have been conducting the "Stop the Headache" program, developed by Heide Denecke and Birgit Kröner-Herwig, in an outpatient setting in close cooperation with Techniker Krankenkasse (a German health insurance company). Building on this, we developed a [...]
On May 2, 2019, the Federal Joint Committee (G-BA) adopted the benefit assessment of erenumab in accordance with Section 35a of the German Social Code, Book V (SGB V). A considerable additional benefit was derived from the submitted data only for adult patients, which did not [...]
The third edition of the International Classification of Headache Disorders (ICHD-3) is now available digitally in German. The digital ICHD-3 makes it much easier to understand the structure and content of the current classification. The practical [...]
What role do triggers play in migraines? The word trigger means something that starts a process. It's like a rifle. When you pull the trigger, the shot goes off. A small event sets off a complex sequence of events. The [...]
According to current understanding, migraine pain is based on a neurogenic inflammatory reaction in the arteries of the meninges. Inflammatory substances are released there in the initial stage of a migraine attack. These lead to increased pain sensitivity of the meninges with swelling and dilation [...]
Foreword to the book by Dr. Martin Leonhard: "Success Factors of My Kiel Migraine Kit" Headaches are the number one public health problem; tension headaches and migraines are the most common neurological disorders in humans. Within a year, [...]
Following erenumab (Aimovig®) on November 1, 2018, the second antibody, galcanezumab (Emgality®), for migraine prophylaxis will also be available in Germany on April 1, 2019. Galcanezumab has been approved in the EU since November 2018. The [...]
Successful as a prophylaxis when other drug therapies have been exhausted: Erenumab, the first drug in a new class for migraine prophylaxis, was launched on the German market in November 2018. An early benefit assessment has shown that [...]
London, 10 January 2019. The National Institute for Health and Care Excellence (NICE) is evaluating guidelines for health technologies, clinical care practices, and prevention on behalf of the UK Department of Health. The [...]
How common is migraine in children? 73.9 percent of seventh graders complain of primary headaches. The most common forms are migraine and tension-type headaches. Nearly 50% of those affected report migraine symptoms [...]
Migraine is the third most common human disease worldwide, after dental caries and tension-type headache [28]. The one-year prevalence in Europe for all forms of migraine is 43.6% in women and 26.9% in men [...]
